NovaBay Pharmaceuticals, Inc. Cash per Share

Cash per Share of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Cash per Share growth rates and interactive chart.


Highlights and Quick Summary

  • Cash per Share for the quarter ending June 30, 2022 was 0.07 (a -33.84% decrease compared to previous quarter)
  • Year-over-year quarterly Cash per Share decreased by -62.94%
  • Annual Cash per Share for 2021 was 0.17 (a -49.55% decrease from previous year)
  • Annual Cash per Share for 2020 was 0.34 (a 6.3% increase from previous year)
  • Annual Cash per Share for 2019 was 0.32 (a 70.39% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Cash per Share of NovaBay Pharmaceuticals, Inc.

Most recent Cash per Shareof NBY including historical data for past 10 years.

Interactive Chart of Cash per Share of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Cash per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.07 0.11
2021 0.17 0.2 0.24 0.25 0.17
2020 0.34 0.34 0.29 0.2 0.34
2019 0.32 0.39 0.2 0.17 0.32
2018 0.19 0.3 0.4 0.51 0.19
2017 0.21 0.4 0.37 0.48 0.21
2016 1.01 0.86 0.47 0.35 1.01
2015 0.86 1.14 2.72 2.57 0.86
2014 2.74 4.49 5.7 8.37 2.74
2013 8.55 7.22 7.65 8.97 8.55
2012 14.32 10.29 9.05 9.93 14.32
2011 13.71 13.14 13.71

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology